Tag:
Protez
Latest Headlines
Latest Headlines
Novartis buys Protez, invests in vaccines
Novartis AG is purchasing U.S.-based antibiotics developer Protez Pharmaceuticals Inc. (Pennsylvania) for a base price of $100 million, but has promised up to $300 million in additional payments
